These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26962561)

  • 21. Contrast-Enhanced Ultrasound and Computed Tomography Assessment of Hepatocellular Carcinoma after Transcatheter Arterial Chemo-Embolization: A Systematic Review.
    Tai CJ; Huang MT; Wu CH; Tai CJ; Shi YC; Chang CC; Chang YJ; Kuo LJ; Wei PL; Chen RJ; Chiou HY
    J Gastrointestin Liver Dis; 2016 Dec; 25(4):499-507. PubMed ID: 27981306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of posttreatment response of hepatocellular carcinoma: comparison of ultrasonography with second-generation ultrasound contrast agent and multidetector CT.
    Salvaggio G; Campisi A; Lo Greco V; Cannella I; Meloni MF; Caruso G
    Abdom Imaging; 2010 Aug; 35(4):447-53. PubMed ID: 19562414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contrast-enhanced ultrasound as a predictor of treatment efficacy within 2 weeks after transarterial chemoembolization of hepatocellular carcinoma.
    Kono Y; Lucidarme O; Choi SH; Rose SC; Hassanein TI; Alpert E; Mattrey RF
    J Vasc Interv Radiol; 2007 Jan; 18(1 Pt 1):57-65. PubMed ID: 17296705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intraarterial contrast-enhanced ultrasound to predict the short-term tumour response of hepatocellular carcinoma to Transarterial chemoembolization with Lipiodol.
    Bo J; Peng H; LianHua Z; Xiang F; YuKun L
    BMC Cancer; 2021 Nov; 21(1):1171. PubMed ID: 34727882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contrast-enhanced Ultrasound Identifies Patent Feeding Vessels in Transarterial Chemoembolization Patients With Residual Tumor Vascularity.
    Wessner CE; Shaw CM; Stanczak M; Forsberg F; Lyshchik A; Tan A; Eisenbrey JR
    Ultrasound Q; 2020 Sep; 36(3):218-223. PubMed ID: 32890324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic response assessment of transcatheter arterial chemoembolization for hepatocellular carcinoma: ultrasonography, CT and MR imaging.
    Minami Y; Kudo M
    Oncology; 2013; 84 Suppl 1():58-63. PubMed ID: 23428860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MDCT versus MRI assessment of tumor response after transarterial chemoembolization for the treatment of hepatocellular carcinoma.
    Kloeckner R; Otto G; Biesterfeld S; Oberholzer K; Dueber C; Pitton MB
    Cardiovasc Intervent Radiol; 2010 Jun; 33(3):532-40. PubMed ID: 19847482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the microcirculation of hepatocellular carcinomas using contrast-enhanced ultrasound with intraarterial and intravenous contrast application during transarterial chemoembolization with drug-eluting beads (DEB-TACE): preliminary data.
    Uller W; Wiggermann P; Gössmann H; Klebl F; Salzberger B; Stroszczynski C; Jung EM
    Clin Hemorheol Microcirc; 2011; 49(1-4):55-66. PubMed ID: 22214678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transarterial chemoembolization with cisplatin as second-line treatment for hepatocellular carcinoma unresponsive to chemoembolization with epirubicin-Lipiodol emulsion.
    Maeda N; Osuga K; Higashihara H; Tomoda K; Mikami K; Nakazawa T; Nakamura H; Tomiyama N
    Cardiovasc Intervent Radiol; 2012 Feb; 35(1):82-9. PubMed ID: 21203761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accurate prediction of responses to transarterial chemoembolization for patients with hepatocellular carcinoma by using artificial intelligence in contrast-enhanced ultrasound.
    Liu D; Liu F; Xie X; Su L; Liu M; Xie X; Kuang M; Huang G; Wang Y; Zhou H; Wang K; Lin M; Tian J
    Eur Radiol; 2020 Apr; 30(4):2365-2376. PubMed ID: 31900703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 3D versus 2D contrast-enhanced sonography in the evaluation of therapeutic response of hepatocellular carcinoma after locoregional therapies: preliminary findings.
    Bartolotta TV; Taibbi A; Matranga D; Midiri M; Lagalla R
    Radiol Med; 2015 Aug; 120(8):695-704. PubMed ID: 25698299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unenhanced and contrast-enhanced ultrasonography during hepatic transarterial embolization and chemoembolization with drug-eluting beads.
    Moschouris H; Malagari K; Kornezos I; Papadaki MG; Gkoutzios P; Matsaidonis D
    Cardiovasc Intervent Radiol; 2010 Dec; 33(6):1215-22. PubMed ID: 20556386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonresectable combined hepatocellular carcinoma and cholangiocarcinoma: analysis of the response and prognostic factors after transcatheter arterial chemoembolization.
    Kim JH; Yoon HK; Ko GY; Gwon DI; Jang CS; Song HY; Shin JH; Sung KB
    Radiology; 2010 Apr; 255(1):270-7. PubMed ID: 20308463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor Vascular Networks Depicted in Contrast-Enhanced Ultrasound Images as a Predictor for Transarterial Chemoembolization Treatment Response.
    Oezdemir I; Wessner CE; Shaw C; Eisenbrey JR; Hoyt K
    Ultrasound Med Biol; 2020 Sep; 46(9):2276-2286. PubMed ID: 32561069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipiodol trans-arterial chemoembolization of hepatocellular carcinoma with idarubicin: first experience.
    Favelier S; Boulin M; Hamza S; Cercueil JP; Cherblanc V; Lepage C; Hillon P; Chauffert B; Krausé D; Guiu B
    Cardiovasc Intervent Radiol; 2013 Aug; 36(4):1039-46. PubMed ID: 23224215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Viable hepatocellular carcinoma around retained iodized oil after transarterial chemoembolization: radiofrequency ablation of viable tumor plus retained iodized oil versus viable tumor alone.
    Kim JH; Kim PN; Won HJ; Shin YM
    AJR Am J Roentgenol; 2014 Nov; 203(5):1127-31. PubMed ID: 25341154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contrast-enhanced ultrasonography with intraarterial administration of SonoVue for guidance of transarterial chemoembolization: an initial experience.
    Moschouris H; Malagari K; Kalokairinou M; Stamatiou K; Marinis A; Papadaki MG
    Med Ultrason; 2011 Dec; 13(4):296-301. PubMed ID: 22132402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microvascular Flow Imaging of Residual or Recurrent Hepatocellular Carcinoma after Transarterial Chemoembolization: Comparison with Color/Power Doppler Imaging.
    Kang HJ; Lee JM; Jeon SK; Ryu H; Yoo J; Lee JK; Han JK
    Korean J Radiol; 2019 Jul; 20(7):1114-1123. PubMed ID: 31270975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatocellular carcinoma: CT for tumor response after transarterial chemoembolization in patients exceeding Milan criteria--selection parameter for liver transplantation.
    Bargellini I; Vignali C; Cioni R; Petruzzi P; Cicorelli A; Campani D; De Simone P; Filipponi F; Bartolozzi C
    Radiology; 2010 Apr; 255(1):289-300. PubMed ID: 20308465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Single center experience over a 5-year period with sequential transarterial chemoembolization (TACE) in the treatment of hepatocellular carcinoma (HCC)].
    Herber SC; Otto G; Woerns M; Moench C; Kanzler S; Junginger T; Schneider J; Schuchmann M; Kummer I; Manzl N; Düber C; Pitton MB
    Rofo; 2007 Mar; 179(3):289-99. PubMed ID: 17325996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.